New shoulder implant shows promise in 87-Patient trial
Disease control
Completed
This study looked at how well a new shoulder replacement system (Catalyst CSR) works and if it is safe. It included 87 adults with shoulder arthritis, bone death, or rheumatoid arthritis. Researchers checked patients' pain, movement, and X-rays for up to 2 years after surgery.
Phase: NA • Sponsor: Catalyst OrthoScience • Aim: Disease control
Last updated May 11, 2026 20:41 UTC